Celgene’s Thalidomide Shown to Improve Cough in Ailment

Thalidomide, the morning-sickness drug linked to birth defects in the 1960s and revived decades later to fight cancer, helped with a debilitating cough tied to a fatal lung condition in a small study.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.